Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory B-Cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06879340
What this trial is testing

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

Who this might be right for
B-Cell Non-Hodgkin LymphomaB-cell Acute Lymphoblastic Leukemia
University of Kansas Medical Center 54
Testing effectiveness (Phase 2)UnknownNCT02851589
What this trial is testing

Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma

Who this might be right for
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaFollicular Lymphoma+3 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT01419691
What this trial is testing

Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic LymphomaLeukemia, Prolymphocytic
University of Kansas Medical Center 15
Early research (Phase 1)Study completedNCT02950220
What this trial is testing

Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+16 more
Kami Maddocks 2
Early research (Phase 1)Study completedNCT02651662
What this trial is testing

Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies

Who this might be right for
Relapsed/Refractory Aggressive B-Cell Lymphoma
Regeneron Pharmaceuticals 105
Early research (Phase 1)Ended earlyNCT00643240
What this trial is testing

Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 1
Very early researchStudy completedNCT03825718
What this trial is testing

GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Hebei Yanda Ludaopei Hospital 29
Testing effectiveness (Phase 2)Study completedNCT02639910
What this trial is testing

Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
MorphoSys AG 24
Early research (Phase 1)Looking for participantsNCT04545762
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Refractory Non-Hodgkin LymphomaBurkitt LymphomaMantle Cell Lymphoma+7 more
C. Babis Andreadis 36
Early research (Phase 1)Study completedNCT00304018
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of California, San Francisco 5
Not applicableNot Yet RecruitingNCT07371533
What this trial is testing

Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319)

Who this might be right for
Acute Lymphocytic Leukemia
Shanxi Bethune Hospital 18
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Ended earlyNCT03698552
What this trial is testing

ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Blasts 5 Percent or More of Bone Marrow Nucleated CellsCD22 PositivePhiladelphia Chromosome Positive+2 more
M.D. Anderson Cancer Center 37
Not applicableStudy completedNCT00919425
What this trial is testing

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 1,294
Testing effectiveness (Phase 2)Study completedNCT00118352
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+61 more
Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00644189
What this trial is testing

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone LymphomaMantle Cell Lymphoma+7 more
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT03389035
What this trial is testing

Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT

Who this might be right for
Acute Lymphoblastic Leukemia, in Relapse
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 21
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Early research (Phase 1)Looking for participantsNCT07775508
What this trial is testing

In Vivo CD19/CD20 CAR T-Cell Therapy for Relapsed/Refractory B-Cell Lymphoma

Who this might be right for
B-cell Lymphoma
Chinese PLA General Hospital 18
Next Page